Lindbrook Capital’s Viking Therapeutics VKTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | $93.9K | Buy |
3,888
+3,430
| +749% | +$82.8K | 0.01% | 707 |
|
|
2024
Q4 | $18.4K | Sell |
458
-88
| -16% | -$3.54K | ﹤0.01% | 1326 |
|
|
2024
Q3 | $34.6K | Buy |
546
+281
| +106% | +$17.8K | ﹤0.01% | 997 |
|
|
2024
Q2 | $14K | Sell |
265
-88
| -25% | -$4.67K | ﹤0.01% | 1440 |
|
|
2024
Q1 | $28.9K | Buy |
353
+278
| +371% | +$22.8K | ﹤0.01% | 1028 |
|
|
2023
Q4 | $1.4K | Sell |
75
-150
| -67% | -$2.79K | ﹤0.01% | 2384 |
|
|
2023
Q3 | $2.49K | Buy |
225
+52
| +30% | +$576 | ﹤0.01% | 2047 |
|
|
2023
Q2 | $2.8K | Hold |
173
| – | – | ﹤0.01% | 2025 |
|
|
2023
Q1 | $2.88K | Buy |
+173
| New | +$2.88K | ﹤0.01% | 2090 |
|
|
2022
Q1 | – | Sell |
-7,500
| Closed | -$35K | – | 2631 |
|
|
2021
Q4 | $35K | Buy |
7,500
+6,855
| +1,063% | +$32K | 0.01% | 840 |
|
|
2021
Q3 | $4K | Hold |
645
| – | – | ﹤0.01% | 1356 |
|
|
2021
Q2 | $4K | Hold |
645
| – | – | ﹤0.01% | 1408 |
|
|
2021
Q1 | $4K | Sell |
645
-164
| -20% | -$1.02K | ﹤0.01% | 1358 |
|
|
2020
Q4 | $5K | Buy |
809
+164
| +25% | +$1.01K | ﹤0.01% | 1213 |
|
|
2020
Q3 | $4K | Hold |
645
| – | – | ﹤0.01% | 1216 |
|
|
2020
Q2 | $5K | Hold |
645
| – | – | ﹤0.01% | 1107 |
|
|
2020
Q1 | $3K | Hold |
645
| – | – | ﹤0.01% | 1231 |
|
|
2019
Q4 | $5K | Hold |
645
| – | – | ﹤0.01% | 1121 |
|
|
2019
Q3 | $4K | Buy |
+645
| New | +$4K | ﹤0.01% | 1126 |
|
|
2019
Q2 | – | Sell |
-1,400
| Closed | -$13K | – | 1517 |
|
|
2019
Q1 | $13K | Sell |
1,400
-3,400
| -71% | -$31.6K | 0.01% | 823 |
|
|
2018
Q4 | $36K | Buy |
+4,800
| New | +$36K | 0.02% | 446 |
|